Sign in
Taking people in SpainPhase 2

Studies sleep and body temperature changes as signs of Alzheimer's in Down syndrome

Studies sleep problems and body temperature rhythms in adults with Down syndrome.

Key facts

Who runs it
Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Where
Barcelona, SpainSee the site
Registry title
Sleep and body temperature as markers of progression of Alzheimer's disease in Down syndrome.
Status
Recruiting
Phase
Phase 2
People taking part
60 people, planned
Started
9 Apr 2024
Expected to end
1 Sept 2027
Type of study
Interventional
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 40 to 60 with Down syndrome and mild or moderate intellectual disability, in good general health. It studies sleep and body temperature as signs of Alzheimer's disease progression.

Age
40 to 60 years
Sex
Women and men can both join.
Disease stage
Down syndrome confirmed by karyotyping. Intellectual disability must be mild or moderate, so the person can complete the CAMCOG cognitive tests.
Earlier treatment
No new psychoactive drugs in the 3 months before the study. No current sedatives or sleeping pills, stimulants, antipsychotics, gabapentin, pregabalin, tricyclic antidepressants, trazodone or other psychoactive drugs that may change sleep or body temperature.

Main reasons for not taking part

  • Cannot give informed consent
  • Significant unstable medical or psychiatric illness
  • Reasons that make an MRI unsafe, such as claustrophobia, a pacemaker or an aneurysm clip
  • Pregnancy
  • Irregular sleep cycles or an extreme mismatch of the body clock lasting 3 months or more

This trial only enrols participants with Down syndrome. The registry sentence this rests on: Subjects with Down syndrome of both sexes between 40 and 60 years.

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Subjects with Down syndrome of both sexes between 40 and 60 years
  • With a degree of intellectual disability that allows completing the CAMCOG cognitive battery.mild or moderate
  • Diagnosis of Down syndrome confirmed by karyotyping
  • Patients with good general health

Who cannot take part

  • Current use of sedatives/hypnotics, stimulants, antipsychotics, gabapentin, pregabalin, tricyclic antidepressants and trazodone, or other psychoactive medications that may alter slow wave sleep (SWS) or body temperature
  • Use of new psychoactive drugs in the three months prior to the study
  • Any significant unstable medical or psychiatric condition or disease
  • Psychiatric illnesses that may affect cognition, such as bipolar disorder or schizophrenia, or the use of medications or substance abuse
  • Gastrointestinal conditions that may present a risk of bowel wall protrusion
  • Medical conditions including uncontrolled pulmonary or cardiac disease, untreated hypothyroidism, brain tumors, stroke, head trauma and hydrocephalus. It should be noted that thyroid status will be assessed by TSHs and Free T3 and T4 at the time of medical screening
  • Inability to give informed consent
  • Common contraindications for MRI (claustrophobia, pacemaker, aneurysm clip, etc.). aneurysm clip, etc.)
  • Pregnancy
  • Irregular sleep cycles, extremely long or short total sleep duration and extreme unstable circadian mismatch (3 months or more)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Spain

  • Hospital de la Santa Creu i Sant PauBarcelona, SpainTaking people

About the trial

What the trial wants to find out

Study the relationship between sleep disorders and circadian variations in body temperature as risk factors for the progression of Alzheimer's disease in Down's syndrome.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Official title
Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study.
Plain-language title
Studies sleep and body temperature changes as signs of Alzheimer's in Down syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2023-506609-21-00, who can take part
Record updated
20 October 2026